Form 4: KORU Medical Systems Director Acquires Shares in Recent Transaction

Director Shahriar Matin acquired 6,329 shares of KORU Medical Systems at $2.37 per share on March 31, 2024.

Summary

• On March 31, 2024, Shahriar Matin, a director of KORU Medical Systems, Inc., acquired 6,329 shares of common stock.
• The shares were purchased at a price of $2.37 per share.
• Following the transaction, Matin directly owns 62,609 shares of KORU Medical Systems.

Sentiment

Score: 6

Explanation: Neutral sentiment. This is a standard regulatory filing detailing a stock purchase by a director. It doesn't inherently indicate positive or negative sentiment about the company's performance, but the purchase itself can be interpreted as a sign of confidence.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment, as insider buying is often viewed favorably.

Key Dates